B.C. biotech company AbCellera Biologics goes public, shares surge 170% on Nasdaq

📆 12.12.2020 1:15:00
📰 VancouverSun

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 61%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

AbCellera says the IPO will raise US$483 million for its business, which analyzes the immune system to help drug developers treat diseases.

The company’s top investors include board member Peter Thiel, a co-founder of PayPal and early investor in Facebook.

AbCellera announced last month it was working with Eli Lilly to develop a treatment for COVID-19, and that its Phase 2 clinical data had received interim authorization by Health Canada.Share this article in your social network

Написать комментарий

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

Россия Последние новости, Россия Последние новости